The objectives of this study are to compare the physiological consequences of high-flow oxygen therapy and noninvasive mechanical ventilation on ventilation, respiratory work and hemodynamics during acute respiratory failure in diffuse interstitial pneumonia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
18
Noninvasive mechanical ventilation is a respiratory technique which allows the administration of positive inspiratory and expiratory airway pressures in order to ventilate the lungs.
Nasal high-flow is a respiratory technique which allows the administration of warmed and humidified air, associated with oxygen.
Continuous positive airway pressure is a respiratory technique which allows to maintain a constant positive airway pressure during inspiration and expiration.
ADIR Association
Rouen, France
Pulmonary compliance
Comparison of global pulmonary compliance (Cglob) under noninvasive ventilation (NIV) and high-flow oxygen therapy (HFO) during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Pulmonary compliance
Comparison of global pulmonary compliance (Cglob) under NIV and continuous positive airway pressure (CPAP) during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Pulmonary compliance
Comparison of global pulmonary compliance (Cglob) under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Pulmonary compliance
Comparison of global pulmonary compliance (Cglob) under HFO and face mask oxygen therapy (FM) during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Pulmonary compliance
Comparison of global pulmonary compliance (Cglob) under NIV and face mask oxygen therapy (FM) during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Pulmonary compliance
Comparison of global pulmonary compliance (Cglob) under CPAP and face mask oxygen therapy (FM) during acute respiratory failure in diffuse interstitial pneumonia.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Tidal volume
Comparison of Tidal volume under CPAP and face mask oxygen therapy (FM) during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Tidal volume
Comparison of Tidal volume under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Tidal volume
Comparison of Tidal volume under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Tidal volume
Comparison of Tidal volume under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Tidal volume
Comparison of Tidal volume under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Tidal volume
Comparison of Tidal volume under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
end-expiratory lung volume
Comparison of end-expiratory lung volume under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
end-expiratory lung volume
Comparison of end-expiratory lung volume under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
end-expiratory lung volume
Comparison of end-expiratory lung volume under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
end-expiratory lung volume
Comparison of end-expiratory lung volume under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
end-expiratory lung volume
Comparison of end-expiratory lung volume under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
end-expiratory lung volume
Comparison of end-expiratory lung volume under FM and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transpulmonary pressure
Comparison of transpulmonary pressure under FM and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transpulmonary pressure
Comparison of transpulmonary pressure under FM and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transpulmonary pressure
Comparison of transpulmonary pressure under FM and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transpulmonary pressure
Comparison of transpulmonary pressure under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transpulmonary pressure
Comparison of transpulmonary pressure under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transpulmonary pressure
Comparison of transpulmonary pressure under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
driving pressure
Comparison of driving pressure under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
driving pressure
Comparison of driving pressure under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
driving pressure
Comparison of driving pressure under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
driving pressure
Comparison of driving pressure under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
driving pressure
Comparison of driving pressure under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
driving pressure
Comparison of driving pressure under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Global inhomogeneity index
Comparison of Global inhomogeneity index under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Global inhomogeneity index
Comparison of Global inhomogeneity index under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Global inhomogeneity index
Comparison of Global inhomogeneity index under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Global inhomogeneity index
Comparison of Global inhomogeneity index under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Global inhomogeneity index
Comparison of Global inhomogeneity index under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Global inhomogeneity index
Comparison of Global inhomogeneity index under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
respiratory rate
Comparison of respiratory rate under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
respiratory rate
Comparison of respiratory rate under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
respiratory rate
Comparison of respiratory rate under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
respiratory rate
Comparison of respiratory rate under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
respiratory rate
Comparison of respiratory rate under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
respiratory rate
Comparison of respiratory rate under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
inspiratory time
Comparison of inspiratory time under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
inspiratory time
Comparison of inspiratory time under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
inspiratory time
Comparison of inspiratory time under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
inspiratory time
Comparison of inspiratory time under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
inspiratory time
Comparison of inspiratory time under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
inspiratory time
Comparison of inspiratory time under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
inspiratory time
Comparison of inspiratory time under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure swings
Comparison of oesophagal pressure variations between inspiration and expiration under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure swings
Comparison of oesophagal pressure variations between inspiration and expiration under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure swings
Comparison of oesophagal pressure variations between inspiration and expiration under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure swings
Comparison of oesophagal pressure variations between inspiration and expiration under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure swings
Comparison of oesophagal pressure variations between inspiration and expiration under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure swings
Comparison of oesophagal pressure variations between inspiration and expiration under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure variations
Comparison of transdiaphragmatic pressure variations between inspiration and expiration under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure variations
Comparison of transdiaphragmatic pressure variations between inspiration and expiration under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure variations
Comparison of transdiaphragmatic pressure variations between inspiration and expiration under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure variations
Comparison of transdiaphragmatic pressure variations between inspiration and expiration under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure variations
Comparison of transdiaphragmatic pressure variations between inspiration and expiration under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure variations
Comparison of transdiaphragmatic pressure variations between inspiration and expiration under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure time products
Comparison of transdiaphragmatic pressure time products under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure time products
Comparison of transdiaphragmatic pressure time products under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure time products
Comparison of transdiaphragmatic pressure time products under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure time products
Comparison of transdiaphragmatic pressure time products under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure time products
Comparison of transdiaphragmatic pressure time products under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transdiaphragmatic pressure time products
Comparison of transdiaphragmatic pressure time products under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure time products
Comparison of oesophagal pressure time products under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure time products
Comparison of oesophagal pressure time products under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure time products
Comparison of oesophagal pressure time products under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure time products
Comparison of oesophagal pressure time products under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure time products
Comparison of oesophagal pressure time products under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
oesophagal pressure time products
Comparison of oesophagal pressure time products under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
ultrasound diaphragmatic strain.
Comparison of ultrasound diaphragmatic strain under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
diaphragmatic thickening fraction
Comparison of diaphragmatic thickening fraction under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
diaphragmatic thickening fraction
Comparison of diaphragmatic thickening fraction under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
diaphragmatic thickening fraction
Comparison of diaphragmatic thickening fraction under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
diaphragmatic thickening fraction
Comparison of diaphragmatic thickening fraction under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
diaphragmatic thickening fraction
Comparison of diaphragmatic thickening fraction under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
diaphragmatic thickening fraction
Comparison of diaphragmatic thickening fraction under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak inspiratory flow
Comparison of peak inspiratory flow under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak inspiratory flow
Comparison of peak inspiratory flow under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak inspiratory flow
Comparison of peak inspiratory flow under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak inspiratory flow
Comparison of peak inspiratory flow under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak inspiratory flow
Comparison of peak inspiratory flow under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak inspiratory flow
Comparison of peak inspiratory flow under FM and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak expiratory flow
Comparison of peak expiratory flow under FM and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak expiratory flow
Comparison of peak expiratory flow under FM and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak expiratory flow
Comparison of peak expiratory flow under FM and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak expiratory flow
Comparison of peak expiratory flow under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak expiratory flow
Comparison of peak expiratory flow under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
peak expiratory flow
Comparison of peak expiratory flow under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Systolic arterial pressures
Comparison of Systolic arterial pressures under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Systolic arterial pressures
Comparison of Systolic arterial pressures under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Systolic arterial pressures
Comparison of Systolic arterial pressures under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Systolic arterial pressures
Comparison of Systolic arterial pressures under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Systolic arterial pressures
Comparison of Systolic arterial pressures under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Systolic arterial pressures
Comparison of Systolic arterial pressures under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Diastolic arterial pressures
Comparison of Diastolic arterial pressures under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Diastolic arterial pressures
Comparison of Diastolic arterial pressures under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Diastolic arterial pressures
Comparison of Diastolic arterial pressures under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Diastolic arterial pressures
Comparison of Diastolic arterial pressures under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Diastolic arterial pressures
Comparison of Diastolic arterial pressures under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Diastolic arterial pressures
Comparison of Diastolic arterial pressures under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Mean arterial pressure
Comparison of Mean arterial pressures under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Mean arterial pressure
Comparison of Mean arterial pressures under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Mean arterial pressure
Comparison of Mean arterial pressures under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Mean arterial pressure
Comparison of Mean arterial pressures under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Mean arterial pressure
Comparison of Mean arterial pressures under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Mean arterial pressure
Comparison of Mean arterial pressures under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
systolic pulmonary arterial pressure
Comparison of systolic pulmonary arterial pressure under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
systolic pulmonary arterial pressure
Comparison of systolic pulmonary arterial pressure under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
systolic pulmonary arterial pressure
Comparison of systolic pulmonary arterial pressure under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
systolic pulmonary arterial pressure
Comparison of systolic pulmonary arterial pressure under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
systolic pulmonary arterial pressure
Comparison of systolic pulmonary arterial pressure under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
systolic pulmonary arterial pressure
Comparison of systolic pulmonary arterial pressure under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
tricuspid annular plane systolic excursion
Comparison of tricuspid annular plane systolic excursion under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
tricuspid annular plane systolic excursion
Comparison of tricuspid annular plane systolic excursion under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
tricuspid annular plane systolic excursion
Comparison of tricuspid annular plane systolic excursion under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
tricuspid annular plane systolic excursion
Comparison of tricuspid annular plane systolic excursion under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
tricuspid annular plane systolic excursion
Comparison of tricuspid annular plane systolic excursion under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
tricuspid annular plane systolic excursion
Comparison of tricuspid annular plane systolic excursion under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right ventricular strain
Comparison of right ventricular strain under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right ventricular strain
Comparison of right ventricular strain under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right ventricular strain
Comparison of right ventricular strain under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right ventricular strain
Comparison of right ventricular strain under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right ventricular strain
Comparison of right ventricular strain under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right ventricular strain
Comparison of right ventricular strain under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
left ventricular ejection fraction
Comparison of left ventricular ejection fraction under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
left ventricular ejection fraction
Comparison of left ventricular ejection fraction under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
left ventricular ejection fraction
Comparison of left ventricular ejection fraction under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
left ventricular ejection fraction
Comparison of left ventricular ejection fraction under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
left ventricular ejection fraction
Comparison of left ventricular ejection fraction under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
left ventricular ejection fraction
Comparison of left ventricular ejection fraction under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
E/E' ratio
Comparison of E/E' ratio under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
E/E' ratio
Comparison of E/E' ratio under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
E/E' ratio
Comparison of E/E' ratio under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
E/E' ratio
Comparison of E/E' ratio under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
E/E' ratio
Comparison of E/E' ratio under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
E/E' ratio
Comparison of E/E' ratio under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right auricular pressure
Comparison of right auricular pressure under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right auricular pressure
Comparison of right auricular pressure under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right auricular pressure
Comparison of right auricular pressure under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right auricular pressure
Comparison of right auricular pressure under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right auricular pressure
Comparison of right auricular pressure under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
right auricular pressure
Comparison of right auricular pressure under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
cardiac output
Comparison of cardiac output under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
cardiac output
Comparison of cardiac output under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
cardiac output
Comparison of cardiac output under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
cardiac output
Comparison of cardiac output under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
cardiac output
Comparison of cardiac output under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
cardiac output
Comparison of cardiac output under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
heart rate
Comparison of heart rate under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
heart rate
Comparison of heart rate under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
heart rate
Comparison of heart rate under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
heart rate
Comparison of heart rate under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
heart rate
Comparison of heart rate under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
heart rate
Comparison of heart rate under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Pulsed oxymetry
Comparison of pulsed oxymetry under NIV and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Pulsed oxymetry
Comparison of pulsed oxymetry under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Pulsed oxymetry
Comparison of pulsed oxymetry under NIV and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Pulsed oxymetry
Comparison of pulsed oxymetry under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Pulsed oxymetry
Comparison of pulsed oxymetry under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Pulsed oxymetry
Comparison of pulsed oxymetry under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transcutaneous carbon dioxide pressure
Comparison of transcutaneous carbon dioxide pressure under CPAP and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transcutaneous carbon dioxide pressure
Comparison of transcutaneous carbon dioxide pressure under CPAP and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transcutaneous carbon dioxide pressure
Comparison of transcutaneous carbon dioxide pressure under CPAP and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transcutaneous carbon dioxide pressure
Comparison of transcutaneous carbon dioxide pressure under FM and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transcutaneous carbon dioxide pressure
Comparison of transcutaneous carbon dioxide pressure under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
transcutaneous carbon dioxide pressure
Comparison of transcutaneous carbon dioxide pressure under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Dyspnea
Comparison of Borg's scale (from 0 to 10, 10 is maximal dyspnea) under HFO and FM during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Dyspnea
Comparison of Borg's scale (from 0 to 10, 10 is maximal dyspnea) under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Dyspnea
Comparison of Borg's scale (from 0 to 10, 10 is maximal dyspnea) under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Dyspnea
Comparison of Borg's scale (from 0 to 10, 10 is maximal dyspnea) under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Dyspnea
Comparison of Borg's scale (from 0 to 10, 10 is maximal dyspnea) under FM and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Dyspnea
Comparison of Borg's scale (from 0 to 10, 10 is maximal dyspnea) under FM and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Comparison of Comfort
Visual comfort scale (from 0 to 10, 10 is maximal confort) under FM and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Comparison of Comfort
Visual comfort scale (from 0 to 10, 10 is maximal confort) under FM and HFO during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Comparison of Comfort
Visual comfort scale (from 0 to 10, 10 is maximal confort) under FM and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Comparison of Comfort
Visual comfort scale (from 0 to 10, 10 is maximal confort) under NIV and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Comparison of Comfort
Visual comfort scale (from 0 to 10, 10 is maximal confort) under HFO and CPAP during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device
Comparison of Comfort
Visual comfort scale (from 0 to 10, 10 is maximal confort) under HFO and NIV during acute respiratory failure in diffuse interstitial pneumonia.
Time frame: During the intervention, after an exposure of 30 minutes to the oxygen therapy device